In the 12-gene signature we proposed, only 2 genes (TDRD5 and FKBP10) have canonical RBDs, indicating that no-canonical RBPs play an indispensable role in CRC prognosis and larger studies covering all RBP sources rather than canonical ones are needed. This evidence concerns the gene FKBP10 and colorectal carcinoma.